Mechanisms of sorafenib resistance. Sorafenib as an anticancer drug is... | Download Scientific Diagram
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
Mechanism of Action | Multikinase Inhibitors
Figure 1 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar
Medicina | Free Full-Text | Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
Mechanisms of Action of Drugs Effective in Hepatocellular Carcinoma - Sarcognato - 2019 - Clinical Liver Disease - Wiley Online Library
Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
Sorafenib (NEXAVAR)®
Mechanism of action of bevacizumab, sorafenib, and sunitinib. Diagram... | Download Scientific Diagram
Systemic Therapies in Hepatocellular Carcinoma
Sorafenib Pharmacodynamics
TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma - Lai - 2019 - Molecular Oncology - Wiley Online Library
Mechanism of Action | NEXAVAR® (sorafenib) Global HCP Website
Sorafenib - Mechanism of Action in treating Advanced Hepatocellular Carcinoma
View of SUSTAINED RELEASE TABLETS OF SORAFENIB-SILIBININ COMBINATIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA | International Journal of Applied Pharmaceutics
Mechanism of action of sorafenib. Sorafenib inhibits the action of... | Download Scientific Diagram
Frontiers | Angiogenesis Inhibitors for the Treatment of Hepatocellular Carcinoma | Pharmacology
Pexa-Vec/Nexavar Combination Fails Phase III Trial in Liver Cancer
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy
Combining Celecoxib with Sorafenib Synergistically Inhibits Hepatocellular Carcinoma Cells In Vitro | Anticancer Research
Sorafenib: 10 years after the first pivotal trial | Future Oncology
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
Sorafenib (Nexavar) - Oncology Nurse Advisor
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
